Related Experiment Videos
Risk Stratification for Vancomycin-Associated Acute Kidney Injury in Chinese Adult Inpatients: A Multicenter
Shu Chen1, Ying Zhang2, Xingyun Hou3
1Department of Pharmacy, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, People's Republic of China.
Infection and Drug Resistance
|July 27, 2026
Summary
Vancomycin-associated acute kidney injury (VA-AKI) affects about 22% of Chinese inpatients. A vancomycin trough of 15.9 mg/L is linked to increased risk, highlighting the need for careful monitoring.
Area of Science:
- Nephrology
- Pharmacology
- Infectious Diseases
Background:
- Vancomycin-associated acute kidney injury (VA-AKI) is a significant clinical concern.
- Identifying reliable vancomycin trough thresholds is crucial for patient safety.
- Understanding risk factors for VA-AKI in diverse populations is essential.
Purpose of the Study:
- To determine a clinically relevant vancomycin trough concentration threshold associated with VA-AKI.
- To identify factors contributing to renal injury in Chinese adult inpatients receiving vancomycin.
- To assess the impact of VA-AKI on patient outcomes.
Main Methods:
- Multicenter retrospective cohort study of 2230 Chinese adult inpatients treated with intravenous vancomycin.
- VA-AKI defined using Kidney Disease: Improving Global Outcomes (KDIGO) criteria.
- Receiver operating characteristic (ROC) analysis and multivariable logistic regression used to identify thresholds and risk factors.
Main Results:
- VA-AKI occurred in 22.1% of patients.
- The vancomycin trough concentration most associated with VA-AKI was 15.9 mg/L.
- Risk factors included contrast exposure, specific antibiotic co-therapy, critical illness, prolonged treatment, cardiac dysfunction, and baseline renal impairment.
Conclusions:
- A vancomycin trough of approximately 15.9 mg/L may serve as a practical threshold for AKI risk stratification.
- Enhanced renal surveillance is recommended for patients with additional risk factors.
- VA-AKI is associated with increased mortality and dialysis requirements.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Acute Kidney Injury II: Pathophysiology
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...